Neovasc Inc
TSX:NVCN

Watchlist Manager
Neovasc Inc Logo
Neovasc Inc
TSX:NVCN
Watchlist
Price: 40.15 CAD Market Closed
Market Cap: 110.8m CAD

Net Margin
Neovasc Inc

-1 082.9%
Current
-1 330%
Average
1.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 082.9%
=
Net Income
-41.2m
/
Revenue
3.8m

Net Margin Across Competitors

No Stocks Found

Neovasc Inc
Glance View

Market Cap
110.5m CAD
Industry
Health Care

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

NVCN Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 082.9%
=
Net Income
-41.2m
/
Revenue
3.8m
What is the Net Margin of Neovasc Inc?

Based on Neovasc Inc's most recent financial statements, the company has Net Margin of -1 082.9%.

Back to Top